| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |